HA+
Live / Applied — Suspended — suspension letter mailed (as of 21 Oct 2025)
What this means for you
Not registered yet, but its 25 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98767760
- Mark type
- Stylized text
- Filed
- 25 Sept 2024
- Attorney of record
- John Zaccaria
Goods and services
- Class 005 — Pharmaceuticals: Implants comprising living tissue; Implants comprising biological tissue and chemical preparations, composed of a combination of sodium hyaluronate and sodium alginate, for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising biological tissue
- Class 010 — Medical apparatus: Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising synthetic material
Owner
- Axogen Corporation, Tampa, FL, US
Prosecution history
- 21 Oct 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 21 Oct 2025 — LETTER OF SUSPENSION E-MAILED
- 21 Oct 2025 — SUSPENSION LETTER WRITTEN
- 01 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 30 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED